Qiming Venture Partners — 2024 Investments
11 investments dated 2024 · listed companies and verified rows first · show all
Akulaku is a payment and digital banking solutions platform serving 33 million customers, offering payment processing, digital banking services, and free shop setup with dedicated traffic support.
B2B MarketplacesFintech
Gordon Hu(Founder)William Li(Founder)
Co-investorsArbor VenturesCapria VenturesDCM VenturesEight Roads VenturesICU VenturesInnoVen Capital+9 more
AusperBio is a Phase II clinical-stage biopharmaceutical company developing oligonucleotide (ASO) therapeutics, with a focus on curative treatments for hepatitis B (HBV).
BiotechHealthtech
Guofeng Cheng(Founder)in
Co-investorsRA Capital
Co-investorsVertex Ventures China
CandidRx develops T-cell engager antibodies to treat autoimmune diseases by redirecting T-cells to eliminate autoreactive B-cells.
BiotechHealthtechSan Diego, US
Ken Song(Chairman, President and CEO)inKenneth Song, M.D.(Executive Officer, Director)Arvind Kush(Executive Officer)Timothy Lu, M.D.(Executive Officer)inBernie Huyghe, Ph.D.(Executive Officer)
BoardJeffrey Tong, Ph.D.(Director)
Co-investorsForesite CapitalForesite LabsLifeSci Venture PartnersOrbiMedSamsara BioCapitalTCG Crossover+3 more
Daxin Jiang(Founder)inJiang Daxin(Founder)
Co-investorsHongShan Capital Group
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Dearer MedicalMufan PowerOriginal PointSONOSILICONTianhu TechnologyVignette Bio
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.












